Beryl Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/09/2025 ,inter alia, to consider and approve consideration and approval of the ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Beryl Drugs Ltd has called a Board Meeting on Tuesday, 2 September 2025 at 11:00 AM at its registered office in Indore. The Board will approve the Board Report, fix the date and notice for the 32nd Annual General Meeting, and set the book closure and e-voting cut-off dates. It will also consider reappointing Mr. Sanjay Sethi (DIN: 00090277) as Managing Director for another 5-year term, subject to shareholder approval. Additionally, Dipika Kataria, Practicing Company Secretary, is proposed to be appointed as Secretarial Auditor for a 5-year period (2025-2030), and as Scrutinizer for the AGM e-voting process.
Routine AGM-related business with no major financial impact disclosed. Shareholders should note the proposed 5-year reappointment of the Managing Director and the new Secretarial Auditor appointment, both of which require their approval at the upcoming AGM.